Skip to Main Content

Paper Details

Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group.
Hum Mutat
28
2018
Author NameAffiliation
Jessica Ezzell HunterCenter for Health Research, Kaiser Permanente Northwest
Leslie G BieseckerNational Human Genome Research Institute, National Institutes of Health
Leslie G BieseckerNational Human Genome Research Institute, National Institutes of Health
Adam H BuchananGenomic Medicine Institute
Kristy LeeUniversity of North Carolina
Noralane M LindorMayo Clinic Arizona
Noralane M LindorMayo Clinic Arizona
Christa Lese MartinAutism & Developmental Medicine Institute
Aleksandar MilosavljevicBaylor College of Medicine
Aleksandar MilosavljevicBaylor College of Medicine
Kathleen F MittendorfCenter for Health Research, Kaiser Permanente Northwest
Ronak Y PatelBaylor College of Medicine
Erin M RamosNational Human Genome Research Institute, National Institutes of Health
Anne SlavotinekUniversity of California san francisco
Anne SlavotinekUniversity of California san francisco
Marc S WilliamsGenomic Medicine Institute
James P EvansUniversity of North Carolina
Katrina A B GoddardCenter for Health Research, Kaiser Permanente Northwest
  • 1 - 18

Datasets